Provided by Tiger Trade Technology Pte. Ltd.

Quanterix Corp

3.41
-0.3000-8.09%
Post-market: 3.410.00000.00%19:46 EDT
Volume:629.49K
Turnover:2.17M
Market Cap:160.49M
PE:-1.30
High:3.72
Open:3.72
Low:3.38
Close:3.71
52wk High:8.77
52wk Low:2.15
Shares:47.06M
Float Shares:38.02M
Volume Ratio:1.00
T/O Rate:1.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6200
EPS(LYR):-2.5130
ROE:-46.48%
ROA:-16.67%
PB:0.68
PE(LYR):-1.36

Loading ...

Quanterix Spotlights Spatial Biology Assay Pipeline Updates at ESSB 2026

Reuters
·
Sep 25

Quanterix Launches PhenoCode 2.0 Molecular Barcoding Kit for Spatial Biology Assays

Reuters
·
Sep 25

Quanterix Grants 260,315 RSUs to New Chief Commercial Officer James Gute Under Inducement Plan

Reuters
·
Sep 17

Quanterix Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 17

Quanterix appoints Yuri Fesko as CMO

TIPRANKS
·
Sep 14

Quanterix Names Yuri Fesko as Chief Medical Officer

Reuters
·
Sep 14

Quanterix Names DR. Yuri Fesko Chief Medical Officer

THOMSON REUTERS
·
Sep 14

Quanterix Files Form 3 for Chief Commercial Officer James Edward Gute Jr

Reuters
·
Aug 19

Quanterix is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Aug 17

Quanterix Director William P. Donnelly Reports Purchase of USD 286,709 in Common Shares

Reuters
·
Aug 15

Sera Prognostics Q2 Revenue Rises on Expanded Partnerships and Medicaid Coverage

Reuters
·
Aug 13

MaxCyte Q2 Revenue Beats Estimates

Reuters
·
Aug 13

Bio-Techne Q4 Revenue Rises 3%, Beats Estimates

Reuters
·
Aug 12

Annexon Biosciences Q2 Net Loss Widens, Cash Runway Extended

Reuters
·
Aug 12

Codexis Q2 Net Loss Narrows, Helped by Lower Operating Expenses

Reuters
·
Aug 12

Harvard Bioscience Q2 Revenue Rises on Telemetry Demand, Lifts 2026 Outlook

Reuters
·
Aug 11

Quanterix Warns of Broad Risk Exposure Despite No New Material Changes in Latest 10-Q

TIPRANKS
·
Aug 11

Interpace Biosciences Q2 Revenue Falls Despite Growth in Thyroid Business

Reuters
·
Aug 11

TELA Bio Q2 Revenue Falls on Lower OviTex PRS Volumes, Withdraws Outlook

Reuters
·
Aug 11

Bionano Genomics Q2 Revenue Rises on Increased Clinical Adoption

Reuters
·
Aug 11